Focus: Infection Control

Judge orders new superbug trial for Olympus

Court said manufacturer didn't properly disclose safety concerns


A King County (Wash.) Superior Court judge ordered a new trial in a wrongful-death case that claimed that a tainted Olympus scope caused the infection that led to a man's death in 2013, according to an article on the Los Angeles Times website.

The judge said Olympus Corp. failed to properly disclose internal emails that raised safety concerns about a redesigned medical scope as early as 2008, several years before the device was publicly tied to deadly superbug outbreaks.

In the first trial, the jury returned a mixed verdict, finding that the device’s design was not unsafe.

The emails — which Olympus shared with the plaintiffs but were not translated from Japanese for the trial as required — suggest that the company was aware of a potential design problem at least four years earlier than has been disclosed.

Read the article.

 



January 24, 2018


Topic Area: Infection Control


Recent Posts

Turning Facility Data Into ROI: Where Healthcare Leaders Should Start

Better data, smarter tools and small facility upgrades can drive measurable returns, guide ambulatory strategy and improve patient experience.


Sutter Health Breaks Ground on Advanced Cancer Center and Care Complex

The new center, located on Sutter’s Memorial Medical Center campus, will feature four stories and 165,000 square feet of modernized, patient-centered space.


Imperial Beach Community Clinic Caught Up in Email Cyberattack

The unusual activity they detected occurred between February 4, 2025, to May 2, 2025.


Social Media Driving Rise in Trade Jobs

Social media is the second largest career influencer for Gen Zers.


North Carolina Children's Receives $25M Gift from Coca-Cola Consolidated

The gift is the first step towards the goal of raising more than $1 billion for the new NC Children’s campus in Apex.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.